Atların influenza virus infeksiyonu (At Gribi)

Atların influenza virusu, duyarlı at populasyonlarındaki solunum sistemi infeksiyonlarının etiyolojisinde önemli rolü olan ve yüksek bulaşma özelliğine sahip viral etkenlerdendir. İnfluenza salgınları, at yetiştiriciliği ve at yarışı endüstrisinde ağır ekonomik kayıplara yol açmaktadır. Bu makale, atların influenza virusunun etiyolojik özellikleri, infeksiyonun epidemiyolojisi, klinik görünümü, immunoloji, patogenez ve patolojisi, tanı, kontrol ve mücadele metotları hakkındaki güncel bilgileri içermektedir.

Anahtar Kelimeler:

klinik görünüm, hastalık önleme, epidemiyoloji, equine influenzavirus, tay, at hastalıkları, at, immünoloji, influenza, patojenez, aşılama (hayvan), viral hastalıklar

Equine influenza virus infection (Equine flu, pferdegrippe)

Equine influenza virus is highly contagious viral agent that causes the respiratory infections of susceptible horse population. Equine influenza outbreaks cause a serious economic impact in horse breeding and racing industry. This article is embraced the recent data about etiological characterization, epidemiology, transmission, clinical signs, pathogenesis, immunology, rapid diagnostic methods, prevention and control of equine influenza infection.

Keywords:

clinical aspects, disease prevention, epidemiology, equine influenzavirus, foals, horse diseases, horses, immunology, influenza, pathogenesis, vaccination, viral diseases,

PDF

___

1. Newton JR, Mumford JA: Equine Influenza. In, Coetzer JAW, Tustin RC (Eds): Infectious Diseases of Livestocks., 766-774. Oxford University Press, Cape Town, Southern Africa, 2004.
2. Myers C, Wilson WD: Equine Influenza. Clin Tech Eq Prac, 5, 187- 196, 2006.
3. Sovinova O, Tumova B, Poutska F, Nemec J: Isolation of a virus causing respiratory disease in horses. Acta Virol, 2, 52-61, 1958.
4. Mumford JA: Control of influenza from an international perspective. In, Wernery U, Wade JF, Mumford JA, Kaaden O-R (Eds): Prooceedings of 8th International Conference on Equine Infectious Diseases, 11-24. R&W Publications Ltd., Newmarket, United Kingdom, 1999.
5. OIE: Equine Influenza. Ch.2.5.5: 686-696, 2004.
6.Paillot R, Hannant D, Kydd JH, Daly JM: Vaccination against equine influenza: Quid novi?. Vaccine, 24, 4047-4061, 2006.
7. Bouvier NM, Palese P: The biology of influenza viruses. Vaccine, 26, D49-D53, 2008.
8. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y: Evolution and ecology of influenza A viruses. Microbiol Rev, 56,152- 179, 1992.
9. Cullinane AA: Updating equine influenza strains in a combined equine influenza and herpesvirus vaccine. Vet J, 167, 118-120, 2004.
10. Daly J, Newton JR, Mumford JA: Current perspectives on control of equine influenza. Vet Res, 35, 411-423, 2004.
11. Daly JM, Lai AC, Binns MM, Chamber TM, Barradeguy M, Mumford JA: Antigenic and genetic evolution of equine H3N8 influenza A viruses. J Gen Virol, 77, 661-671, 1996.
12. Van Oirschot JT, Masurel N, Huffels ADNH, Anker WJJ: Equine influenza in the Netherlands during the winter of 1978-1979: Antigenic drift of the A-equi 2 virus. Vet Q, 3, 81-84, 1981.
13. Gerber H: Clinical features, sequelae and epidemiology of equine influenza. In, Bryans JT (Ed): Prooceedings of the Second International Conference on Equine Infectious Diseases., 51-59. Kentucky University Press, Lexington, 1970.
14. Ismail TM, Sami AM, Youssef HM, Abou Zaid AA: An outbreak of equine influenza type 1 in Egypt in 1989. Vet Med J Giza, 38, 195- 206, 1990.
15. Madic J, Martinovic S, Naglic T, Hajsig D, Cvetnic S: Serological evidence fort he presence of A/equine-1 influenza virus in unvaccinated horses in Croatia. Vet Rec, 138, 68, 1996.
16. Abd El-Rahim JH, Hussein M: An epizootic of equine influenza in Upper Egytp in 2000. Rev Sci Tech, 23, 921-930, 2004.
17. Borchers K, Daly J, Stiens G, Kreling K, Kreling I, Ludwig H: Characterisation of three equine influenza A H3N8 viruses from Germany (2000 and 2002): Evidence for frozen evolution. Vet Microbiol, 107, 13-21, 2005.
18. Goto H, Shimizu K, Abe T, Kanamitsu M: Sero-epidemiological study on equine influenza in Japan. J Clin Microbiol, 2, 89-93, 1975.
19. Guo Y, Wang M, Zheng GS, Li WK, Kawaoka Y, Webster RG: Seroepidemiological and molecular evidence for the presence of two H3N8 equine influenza viruses in China in 1993-94. J Gen Virol, 76, 2009-2014, 1995.
20. Animal Health Trust: Equine disease surveillance, April to June 2008. Vet Rec, 27, 377-380, 2008.
21. Uppal PK, Yadav MP, Oberoi MS: Isolation of A/Equi-2 virus during 1987 equine influenza epidemic in India. Eq Vet J, 21, 364- 366, 1989.
22. Crawford PC, Dubovi EJ, Castleman WL, Stephenson I, Gibbs EPJ, Chen L, Smith C, Hill RC, Ferro P, Pompey J, Bright RA, Medina MJ, Influenza Genomics Group: Transmission of equine influenza virus to dogs. Science, 310, 482-485, 2005.
23. Etchegaray PB: Influenza equina en Chile (1963-1992). Un posible caso en un ser humano. Rev Chil Infect, 22, 47-50, 2005.
24. Britton AP, Robinson JH: Isolation of influenza A virus from a 7- day-old foal with bronchointerstitiel pneumonia. Can Vet J, 43, 55- 56, 2002.
25. Daly JM, Mumford JA: Influenza infections. In, Lekeux P (Ed): Equine respiratory diseases, http://www.ivis.org/ special_books/ Lekeux/daly/chapter_frm.asp?LA=1, 2001. Accessed: 15.01.2008
26. Hannant D, Mumford JA, Jessett DM: Duration of circulating antibody and immunity following infection with equine influenza virus. Vet Rec,122,125-128, 1988.
27. Patterson-Kane JC, Carrick JB, Axon JE, Wilkie I, Begg AP: The pathology of bronchointerstitiel pneumonia in young foals associated with the first outbreak of equine influenza in Australia. Eq Vet J, 40, 1- 5, 2008.
28. Hannant D: Immune responses to common respiratory pathogens: problems and perspectives in equine immunology. In, Rossdale PD, Arnold AF, Holmes MA, (Eds): Equine Immunology. Eq Vet J, 12, 10- 18, 1991.
29. Ada G, Jones PD: The immune response to influenza infection. Curr Top Microbiol Immunol, 128, 1-54, 1986.
30. Quinlivan M, Cullinane A, Nelly M, Van Maanen K, Heldens J, Arkins S: Comparison of sensitivities of virus isolation, antigen detection and nucleic acid amplification for detection of equine influenza virus. J Clin Microbiol, 42, 759-763, 2004.
31. Morley PS, Bogdan JR, Townsend HGG, Haines DM: Evaluation of Directigen Flu A assay for detection of influenza antigen in nasal secretions of horses. Eq Vet J, 27, 131-134, 1995.
32. Ozaki H, Sugiura T, Sugita S, Imawaga H, Kida H: Detection of antibodies to the non-structural protein (NS1) of influenza A virus allows distinction between vaccinated and infected horses. Vet Microbiol, 82, 111-119, 2001.
33. Yamanaka T, Tsujimura K, Kondo T, Hobo S, Matsumura T: Efficacy of oseltamivir phosphate to horses inoculated with equine influenza A virus. J Vet Med Sci, 68, 923-928, 2006.
34. Park AW, Wood JLN, Newton JR, Daly J , Mumford JA, Grenfell BT: Optimising vaccination strategies in equine influenza. Vaccine, 21, 2862-2870, 2003.
35. Global Surveillance Network for Equine Influenza. www.equiflunet.org.uk. 23.10.2008
36. Nelson KM, Schram BR, McGregor MW, Sheoran AS, Olsen CW, Lunn DP: Local and systemic isotype-spesific antibody responses to equine influenza virus infection versus conventional vaccination. Vaccine, 16, 1306-1313, 1998.
37. Cullinane AA, Weld J, Osborne M, Nelly M, McBride C, Walsh C: Field studies on equine influenza vaccination regimes in throughbred foals and yearlings. Vet J, 161, 174-185, 2001.
38. Newton JR, Lakhani KH, Wood JLN, Baker DJ: Risk factors for equine influenza serum antibody titres in young Throughbred racehorses given an inactivated vaccine. Prev Vet Med, 46, 129-141, 2000.
39. Mumford JA, Wilson H, Hannant D, Jessett DM: Antigenicity and immunogenicity of equine influenza vaccines containing a carbomer adjuvant. Epidemiol Infect, 112, 421-437, 1994.
40. Mumford JA, Jessett DM, Rollinson EA, Hannant D, Draper ME: Duration of protective efficacy of equine influenza immunostimulating complex/tetanus vaccines. Vet Rec, 134, 158- 162, 1994
41. Soboll G, Horohov DW, Aldridge BM, Olsen CW, McGregor MW, Drape RJ, Macklin WF, Lunn DP: Regional antibody and cellular immune reponses to equine influenza virus infection, and particle mediated DNA vaccination. Vet Immunol Immunopathol, 94, 47-62, 2003.
42. Lunn DP, Olsen CW, Soboll G, McGregor MW, Drape RJ, Macklin WF, Mc Cabe DE, Swain WF: Development of practical DNA vaccination strategies for use in horses. In, Wernery U, Wade JF, Mumford JA, Kaaden O-R (Eds): Prooceedings of 8th International Conference on Equine Infectious Diseases, 38-43. R&W Publications Ltd., Newmarket, United Kingdom, 1999.
43. Arda M, Sareyyüpoğlu B: Nukleik asit aşVlarV (DNA ve cDNA aşVlarV). In, AşVlar, HazVrlama Teknikleri, Avantaj ve DezavantajlarV, 58-84. İnkansa MatbaacVlVk Ltd.Şti, Ankara, 2004.
44. Whitaker-Dowling P, Youngner JS, Chambers TM, Heska Corporation Collaborative Group: A new intranasal, modified-live virus vaccine for equine H3N8 influenza. International Congress Series, 1219, 961-964, 2001.
45. Edlund Toulemonde C, Daly J, Sindle T, Guigal PM, Audonnet JC, Minke JM: Efficacy of a recombinant equine influenza vaccine against challenge with an American lineage H3N8 influenza virus responsible for the 2003 outbreak in the United Kingdom. Vet Rec, 156, 367-371, 2005.
46. Minke JM, Edlund Toulemonde C, Diniç S, Cozette V, Cullinane A, Audonnet JC: Effective priming of foals born to immune dams against influenza by a canarypox-vectored recombinant influenza H3N8 vaccine. J Comp Pathol, 137, S76-S80, 2007.
47. Van Oirschot JT, Bruin G, De Boer-Luytze E, Smolders G: Maternal antibodies against equine influenza virus in foals and their interference with vaccination. Zentralbl Veterinarmed B, 38, 391- 396, 1991.
48. Yılmaz S, Karaman Z, Güler E: Türkiye’de enflüenza eqüi enfeksiyonunun ilk defa çVkVşV (the fist outbreak of equine influenza in Turkey). Etlik Vet Mikrobiyol Derg, 5, 5-16, 1985.
49. Ataseven VS, Daly JM: Seroepidemiology of equine influenza virus infection in Turkey. Turk J Vet Anim Sci, 31, 199-202, 2007.